Bright light treatment of depression for older adults [ISRCTN55452501]

Loving, Richard T.; Kripke, Daniel F.; Elliott, Jeffrey A.; Knickerbocker, Nancy C.; Grandner, Michael A.
January 2005
BMC Psychiatry;2005, Vol. 5, p41
Academic Journal
Background: The incidence of insomnia and depression in the elder population is significant. It is hoped that use of light treatment for this group could provide safe, economic, and effective rapid recovery. Methods: In this home-based trial we treated depressed elderly subjects with bright white (8,500 Lux) and dim red (<10 Lux) light for one hour a day at three different times (morning, mid-wake and evening). A placebo response washout was used for the first week. Wake treatment was conducted prior to the initiation of treatment, to explore antidepressant response and the interaction with light treatment. Urine and saliva samples were collected during a 24-hour period both before and after treatment and assayed for aMT6s and melatonin respectively to observe any change in circadian timing. Subjects wore a wrist monitor to record light exposure and wrist activity. Daily log sheets and weekly mood (GDS) and physical symptom (SAFTEE) scales were administered. Each subject was given a SCID interview and each completed a mood questionnaire (SIGH-SAD-SR) before and after treatment. Also, Hamilton Depression Rating (SIGH-SAD version) interviews were conducted by a researcher who was blind to the treatment condition. A control group of healthy, age-matched, volunteers was studied for one day to obtain baseline data for comparison of actigraphy and hormone levels. Results: Eighty-one volunteers, between 60 and 79 years old, completed the study. Both treatment and placebo groups experienced mood improvement. Average GDS scores improved 5 points, the Hamilton Depression Rating Scale (HDRS) 17 scores (extracted from the self-rated SIGH-SAD-SR) improved 6 points. There were no significant treatment effects or time-by-treatment interactions. No significant adverse reactions were observed in either treatment group. The assays of urine and saliva showed no significant differences between the treatment and placebo groups. The healthy control group was active earlier and slept earlier but received less light than the depressed group at baseline. Conclusion: Antidepressant response to bright light treatment in this age group was not statistically superior to placebo. Both treatment and placebo groups experienced a clinically significant overall improvement of 16%.


Related Articles

  • The Nature of Depression Among Older People in Inner London, and the Contact with Primary Care. Blanchard, M.R.; Waterreus, A.; Mann, A.H. // British Journal of Psychiatry;Mar94, Vol. 164, p396 

    Ninety-six people of pensionable age from an inner-London electoral ward who had been identified by short-CARE screening as having 'probable pervasive depression' were interviewed further to ascertain their GMS-AGECAT and self-CARE status, comorbid features, and current primary-care psychiatric...

  • Serotonin transporter genotype interacts with paroxetine plasma levels to influence depression treatment response in geriatric patients. Lotrich, Francis E.; Pollock, Bruce G.; Kirshner, Margaret; Ferrell, Robert F.; Reynolds III, Charles F. // Journal of Psychiatry & Neuroscience;Mar2008, Vol. 33 Issue 2, p123 

    Objective: To investigate whether variable antidepressant response may be influenced by an interaction between the serotonin transporter promoter polymorphism (5-HTTLPR) and antidepressant concentration. Methods: Elderly subjects with depression treated with paroxetine ( n = 110) were genotyped...

  • Prevalence of dementia and depression among elderly people in Black and ethnic minorities. McCracken, C. F. M.; Boneham, M. A.; Copeland, J. R. M.; Williams, K. E.; Wilson, K.; Scott, A.; McKibbin, P.; Cleave, N. // British Journal of Psychiatry;Sep97, Vol. 171, p269 

    Background This study was designed to identify all elderly people of ethnic minorities living in a defined geographical area in inner-city Liverpool and to identify psychiatric morbidity and barriers to use of services. This paper reports the prevalence of dementia and depression. Method A...

  • An investigation of factors identified at birth in relation to anxiety and depression in old age: the Hordaland Health Study (HUSK). Skogen, Jens Christoffer; Stewart, Robert; Mykletun, Arnstein; Knapstad, Marit; Øverland, Simon // BMC Psychiatry;2013, Vol. 13 Issue 1, p1 

    Background: Although life course influences have long been recognised in affective disorder, little is known about the influence of early life factors on late life anxiety and depression. The aim was to investigate the extent to which birth measures, maternal health and family circumstances were...

  • Depression in inactive and active elderly women practitioners of dance, weight-lifting or meditation. Castro, Juracy C.; Giani, Tania S.; Ferreira, Márcia A.; Bastos, Fernando A. C.; Cruz, Thales H. P.; Boechat, Rosane; Dantas, Estélio H. M. // Acta Medica Lituanica;2009, Vol. 16 Issue 1/2, p52 

    Background. The aim of the study was to confront inactive (control group) to active (practicing weight-lifting, dance or meditation) elderly women for investigating the impacts of depression. Analysing the hypothesis that depression in old age is commonly associated with inactivity, this study...

  • Depression in Later Life. Talerico, Karen Amann; Kurlowicz, Lenore H. // Journal of Psychosocial Nursing & Mental Health Services;Jan2005, Vol. 43 Issue 1, p16 

    Discusses depression in later life. List of pejorative stereotypes affecting older adults with depression; Positive findings from research on mental health and aging; Effects of mental health interventions in later life; Aspects of Alzheimer's disease that most affect patient coping, family...

  • Dyskinesia: case report.  // Reactions Weekly;7/16/2005, Issue 1060, p13 

    The article presents a case of a 63-year-old man with dyskinesia. The patient developed mild to moderate movement disorders an hour after receiving his first dose of mirtazapine for treating depression.

  • Understanding Depression and Cognitive Impairment in the Elderly. Walker, Ellen M.; Steffens, David C. // Psychiatric Annals;Jan2010, Vol. 40 Issue 1, p29 

    The article discusses the prevalence of depression and cognitive impairment in elderly people. Geriatric psychiatrists acknowledge that late-life depression is both a cognitive and mood disorder. The study does not suggest that depressed elderly people are destined for cognitive decline and...

  • Measuring Depression in Canada's Elderly Chinese Population: Use of a Community Screening Instrument. Lai, Daniel W.L. // Canadian Journal of Psychiatry;Apr2000, Vol. 45 Issue 3, p279 

    Objective: To assess the reliability and validity of a 15-item Chinese Geriatric Depression Scale (GDS) to measure depression in Canada's elderly Chinese population.Method: A random sample of 96 elderly Chinese in a Canadian city was surveyed by telephone. The measure of depression used was the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics